{"DataElement":{"publicId":"2967294","version":"1","preferredName":"Primary Malignant Neoplasm Anatomic Site Primary Tumor Count","preferredDefinition":"The numeric value related to the number of primary malignant neoplasm tumors.","longName":"2967287v1.0:2222055v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2967287","version":"1","preferredName":"Primary Malignant Neoplasm Anatomic Site","preferredDefinition":"Occurring first in time or sequence; original; of greatest rank or importance or value._A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._Named locations of or within the body.","longName":"2526559v1.0:2186622v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2526559","version":"1","preferredName":"Primary Malignant Neoplasm","preferredDefinition":"Occurring first in time or sequence; original. (American Heritage Dictionary):A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C25251:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1F768442-4F07-0998-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-10","endDate":null,"createdBy":"PWEST","dateCreated":"2006-10-10","modifiedBy":"ONEDATA","dateModified":"2006-10-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2186622","version":"1","preferredName":"Anatomic Site","preferredDefinition":"Named locations of, or within, the body.","longName":"C13717","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anatomic Site","conceptCode":"C13717","definition":"Named locations of or within the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-B313-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-05","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":"Updated to point to NCI Thesaurus concept code.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008526","version":"1","preferredName":"Anatomic Sites","preferredDefinition":"locations or structures in the human body.","longName":"ANAT_SITES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ED0F8B-4D91-332D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AB133FF-9BF1-BF80-E040-BB89AD43245B","latestVersionIndicator":"Yes","beginDate":"2009-12-14","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-14","modifiedBy":"KUMMEROA","dateModified":"2017-07-04","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2222055","version":"1","preferredName":"Primary Tumor Count","preferredDefinition":"Count of the number of tumors classified as primaries, not sites of metastatic disease.","longName":"PRIM_TUM_CT","context":"CCR","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2183055","version":"3","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary)","longName":"DIAGNOSIS","context":"TEST","contextVersion":"1","origin":null,"workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"DBD12DB3-8C3C-49A1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-06-01","endDate":"2022-05-24","createdBy":"DWARZEL","dateCreated":"2004-06-01","modifiedBy":"DWARZEL","dateModified":"2022-05-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184284","version":"1","preferredName":"Count","preferredDefinition":"Count; the total number counted","longName":"Count","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Count","conceptCode":"C25463","definition":"Determining the number or amount of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1AE6-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F54516A5-24B0-25D2-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-26","modifiedBy":"REEVESD","dateModified":"2005-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"neu_base_diag_adglnd_num","type":"NMDP_FN","context":"NHLBI"},{"name":"neu_base_diag_bm_num","type":"NMDP_FN","context":"NHLBI"},{"name":"neu_base_diag_bone_num","type":"NMDP_FN","context":"NHLBI"},{"name":"neu_base_diag_cnerve_num","type":"NMDP_FN","context":"NHLBI"},{"name":"neu_base_diag_crbllm_num","type":"NMDP_FN","context":"NHLBI"},{"name":"neu_base_diag_crbrum_num","type":"NMDP_FN","context":"NHLBI"},{"name":"neu_base_diag_csf_num","type":"NMDP_FN","context":"NHLBI"},{"name":"neu_base_diag_liver_num","type":"NMDP_FN","context":"NHLBI"},{"name":"neu_base_diag_lynode_num","type":"NMDP_FN","context":"NHLBI"},{"name":"neu_base_diag_medstm_num","type":"NMDP_FN","context":"NHLBI"},{"name":"neu_base_diag_oth_num","type":"NMDP_FN","context":"NHLBI"},{"name":"neu_base_diag_pspgng_num","type":"NMDP_FN","context":"NHLBI"},{"name":"neu_base_diag_rorbit_num","type":"NMDP_FN","context":"NHLBI"},{"name":"neu_base_diag_skin_num","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedClinicalResult:value","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Number of tumors present:","type":"Preferred Question Text","description":"Number of tumors present:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping for CDE:2967294","type":"BRIDG Mapping Path","description":"PerformedClinicalResult.value(ANY=>INT.NONNEG) WHERE PerformedDiagnosis.value=Neuroblastoma\" AND PerformedObservation > DefinedObservation.nameCode = \"Determine Number of Tumors\" AND PerformedDiagnosis > AssessedResultRelationship > PerformedObservation","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AB133FF-9D0A-BF80-E040-BB89AD43245B","latestVersionIndicator":"Yes","beginDate":"2009-12-14","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-14","modifiedBy":"KUMMEROA","dateModified":"2021-03-15","changeDescription":". 2021-3-15 ak OK to release per WZ.  2021-3-3 ak System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}